Prazosin Displays Anticancer Activity against Human Prostate Cancers: Targeting DNA, Cell Cycle

Quinazoline-based α1,-adrenoceptor antagonists, in particular doxazosin, terazosin, are suggested to display antineoplastic activity against prostate cancers. However, there are few studies elucidating the effect of prazosin. In this study, prazosin displayed antiproliferative activity superior to t...

Full description

Bibliographic Details
Main Authors: Ssu-Chia Lin, Shih-Chieh Chueht, Che-Jen Hsiao, Tsia-Kun Li, Tzu-Hsuan Chen, Cho-Hwa Liao, Ping-Chiang Lyu, Jih-Hwa Guh
Format: Article
Language:English
Published: Elsevier 2007-10-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558607800637
_version_ 1819057510552698880
author Ssu-Chia Lin
Shih-Chieh Chueht
Che-Jen Hsiao
Tsia-Kun Li
Tzu-Hsuan Chen
Cho-Hwa Liao
Ping-Chiang Lyu
Jih-Hwa Guh
author_facet Ssu-Chia Lin
Shih-Chieh Chueht
Che-Jen Hsiao
Tsia-Kun Li
Tzu-Hsuan Chen
Cho-Hwa Liao
Ping-Chiang Lyu
Jih-Hwa Guh
author_sort Ssu-Chia Lin
collection DOAJ
description Quinazoline-based α1,-adrenoceptor antagonists, in particular doxazosin, terazosin, are suggested to display antineoplastic activity against prostate cancers. However, there are few studies elucidating the effect of prazosin. In this study, prazosin displayed antiproliferative activity superior to that of other α1-blockers, including doxazosin, terazosin, tamsulosin, phentolamine. Prazosin induced G2 checkpoint arrest, subsequent apoptosis in prostate cancer PC-3, DU-145, LNCaP cells. In p53-null PC-3 cells, prazosin induced an increase in DNA str, breaks, ATM/ATR checkpoint pathways, leading to the activation of downstream signaling cascades, including Cdc25c phosphorylation at Ser216, nuclear export of Cdc25c, cyclin-dependent kinase (Cdk) 1 phosphorylation at Tyr15. The data, together with sustained elevated cyclin A levels (other than cyclin B1 levels), suggested that Cdki activity was inactivated by prazosin. Moreover, prazosin triggered mitochondria-mediated, caspaseexecuted apoptotic pathways in PC-3 cells. The oral administration of prazosin significantly reduced tumor mass in PC-3-derived cancer xenografts in nude mice. In summary, we suggest that prazosin is a potential antitumor agent that induces cell apoptosis through the induction of DNA damage stress, leading to Cdki inactivation, G2 checkpoint arrest. Subsequently, mitochondriamediated caspase cascades are triggered to induce apoptosis in PC-3 cells.
first_indexed 2024-12-21T13:40:27Z
format Article
id doaj.art-9c469a29db2940449599a3e83b9f2422
institution Directory Open Access Journal
issn 1476-5586
1522-8002
language English
last_indexed 2024-12-21T13:40:27Z
publishDate 2007-10-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-9c469a29db2940449599a3e83b9f24222022-12-21T19:02:02ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022007-10-0191083083910.1593/neo.07475Prazosin Displays Anticancer Activity against Human Prostate Cancers: Targeting DNA, Cell CycleSsu-Chia Lin0Shih-Chieh Chueht1Che-Jen Hsiao2Tsia-Kun Li3Tzu-Hsuan Chen4Cho-Hwa Liao5Ping-Chiang Lyu6Jih-Hwa Guh7School of Pharmacy, National Taiwan University, Taipei, TaiwanDepartment of Urology, National Taiwan University Hospital, Taipei, TaiwanDepartment of Life Sciences, Institute of Bioinformatics, Structural Biology, National Tsing Hua University, Hsinchu, TaiwanDepartment of Microbiology, College of Medicine, National Taiwan University, Taipei, TaiwanSchool of Pharmacy, National Taiwan University, Taipei, TaiwanSchool of Pharmacy, National Taiwan University, Taipei, TaiwanDepartment of Life Sciences, Institute of Bioinformatics, Structural Biology, National Tsing Hua University, Hsinchu, TaiwanSchool of Pharmacy, National Taiwan University, Taipei, TaiwanQuinazoline-based α1,-adrenoceptor antagonists, in particular doxazosin, terazosin, are suggested to display antineoplastic activity against prostate cancers. However, there are few studies elucidating the effect of prazosin. In this study, prazosin displayed antiproliferative activity superior to that of other α1-blockers, including doxazosin, terazosin, tamsulosin, phentolamine. Prazosin induced G2 checkpoint arrest, subsequent apoptosis in prostate cancer PC-3, DU-145, LNCaP cells. In p53-null PC-3 cells, prazosin induced an increase in DNA str, breaks, ATM/ATR checkpoint pathways, leading to the activation of downstream signaling cascades, including Cdc25c phosphorylation at Ser216, nuclear export of Cdc25c, cyclin-dependent kinase (Cdk) 1 phosphorylation at Tyr15. The data, together with sustained elevated cyclin A levels (other than cyclin B1 levels), suggested that Cdki activity was inactivated by prazosin. Moreover, prazosin triggered mitochondria-mediated, caspaseexecuted apoptotic pathways in PC-3 cells. The oral administration of prazosin significantly reduced tumor mass in PC-3-derived cancer xenografts in nude mice. In summary, we suggest that prazosin is a potential antitumor agent that induces cell apoptosis through the induction of DNA damage stress, leading to Cdki inactivation, G2 checkpoint arrest. Subsequently, mitochondriamediated caspase cascades are triggered to induce apoptosis in PC-3 cells.http://www.sciencedirect.com/science/article/pii/S1476558607800637PrazosinDNA damagecell cycleCdc25cmitochondriainvolved apoptosis
spellingShingle Ssu-Chia Lin
Shih-Chieh Chueht
Che-Jen Hsiao
Tsia-Kun Li
Tzu-Hsuan Chen
Cho-Hwa Liao
Ping-Chiang Lyu
Jih-Hwa Guh
Prazosin Displays Anticancer Activity against Human Prostate Cancers: Targeting DNA, Cell Cycle
Neoplasia: An International Journal for Oncology Research
Prazosin
DNA damage
cell cycle
Cdc25c
mitochondriainvolved apoptosis
title Prazosin Displays Anticancer Activity against Human Prostate Cancers: Targeting DNA, Cell Cycle
title_full Prazosin Displays Anticancer Activity against Human Prostate Cancers: Targeting DNA, Cell Cycle
title_fullStr Prazosin Displays Anticancer Activity against Human Prostate Cancers: Targeting DNA, Cell Cycle
title_full_unstemmed Prazosin Displays Anticancer Activity against Human Prostate Cancers: Targeting DNA, Cell Cycle
title_short Prazosin Displays Anticancer Activity against Human Prostate Cancers: Targeting DNA, Cell Cycle
title_sort prazosin displays anticancer activity against human prostate cancers targeting dna cell cycle
topic Prazosin
DNA damage
cell cycle
Cdc25c
mitochondriainvolved apoptosis
url http://www.sciencedirect.com/science/article/pii/S1476558607800637
work_keys_str_mv AT ssuchialin prazosindisplaysanticanceractivityagainsthumanprostatecancerstargetingdnacellcycle
AT shihchiehchueht prazosindisplaysanticanceractivityagainsthumanprostatecancerstargetingdnacellcycle
AT chejenhsiao prazosindisplaysanticanceractivityagainsthumanprostatecancerstargetingdnacellcycle
AT tsiakunli prazosindisplaysanticanceractivityagainsthumanprostatecancerstargetingdnacellcycle
AT tzuhsuanchen prazosindisplaysanticanceractivityagainsthumanprostatecancerstargetingdnacellcycle
AT chohwaliao prazosindisplaysanticanceractivityagainsthumanprostatecancerstargetingdnacellcycle
AT pingchianglyu prazosindisplaysanticanceractivityagainsthumanprostatecancerstargetingdnacellcycle
AT jihhwaguh prazosindisplaysanticanceractivityagainsthumanprostatecancerstargetingdnacellcycle